Trial intelligence / Profile preview

CRH Effect on Esophageal Sensitivity in Healthy Volunteers

NCT02674256Phase 4Completed

Sponsor
UZ Leuven
Start
Mar 2014
Primary completion
May 2014
Modality
Peptides, Recombinant Proteins and Enzymes
01

Overview

A Phase 4 trial of corticorelin ovine triflutate, sponsored by UZ Leuven. Started Mar 2014; status: completed.

02

Drugs

corticorelin ovine triflutate

Beyond the preview

Go deeper on NCT02674256.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02674256.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call